Cargando…
Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry
AIM: This study sought to assess whether radial artery access improves clinical outcomes in patients presenting with acute myocardial infarction compared with femoral artery access. METHODS: This is a single-centre, prospective observational registry of all STEMI and NSTEMI patients who underwent co...
Autores principales: | Kilic, S., Hermanides, R. S., Ottervanger, J. P., Kolkman, E., Dambrink, J. H. E., Roolvink, V., Gosselink, A. T. M., Kedhi, E., van ’t Hof, A. W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179360/ https://www.ncbi.nlm.nih.gov/pubmed/27561283 http://dx.doi.org/10.1007/s12471-016-0887-6 |
Ejemplares similares
-
Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry
por: Badings, E. A., et al.
Publicado: (2018) -
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
por: Schellings, Dirk AAM, et al.
Publicado: (2016) -
The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study
por: Postma, Sonja, et al.
Publicado: (2015) -
Impact of opioids on P2Y(12) receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, Anne H, et al.
Publicado: (2020) -
A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, A. H., et al.
Publicado: (2019)